←
Inner Compass Initiative9,589 posts
Inner Compass Initiative avatar

Inner Compass Initiative

@_innercompass

We’re a nonprofit that helps people make informed choices about psychiatric drugs and provides resources for those considering or undertaking a taper.

◷ Joined May 2016▧ 3,737 Photos and videos
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Aug 22

What shaped the mental health system we have today, and where do we go from here? Join us in Boston for The Future of Mental Health in America, January 26–28, 2027 where we’ll explore those questions together. We’ll examine the historical, scientific, institutional, and cultural forces shaping mental health care and explore new possibilities for the future. Last year’s inaugural conference sold out because it created space for honest, constructive conversations that rarely happen elsewhere. This year, we’re bringing that spirit back and building on it. Early bird tickets are now on sale — limited quantities available. Visit the link below for full details and reserve your place.

Post attachmentPost attachmentPost attachmentPost attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·6h

More and more psychiatrists are looking to the latest research and the bigger picture to put informed choice at the heart of their practice, including deprescribing. One of those psychiatrists is Swapnil Gupta, and she’ll be speaking at our conference in January, where we’re bringing together people whose lives, work, and ways of thinking look beyond the existing, medicalized mental health industry to a future that starts from people’s own experiences. Here’s a little more about her and what you can look forward to from her talk. You can join her January 26–28, 2027 in Boston—link below to get your tickets now.

Post attachmentPost attachmentPost attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 15

Concerns about the effects of antidepressants on aquatic organisms have become so pressing that researchers are developing ways to remove them from water, as a new study published last month shows. Drugs such as fluoxetine and venlafaxine pass through ordinary treatment plants and reach rivers and coastal waters. At the levels found in those waters, they alter fish behavior and reproduction, affect cell function and larval development in mussels and other invertebrates, and slow photosynthesis in algae — the ability to turn sunlight into energy. The study tested a specialized material designed to pull both drugs out of water at the same time, including from real wastewater. If you prescribe, research, or study these drugs — or if you work in aquatic ecology or environmental science — this is part of the larger picture of what happens after they leave the body. It’s also one more measurable consequence of widespread prescribing of antidepressants that exists whether or not you ever take them yourself. Link below for the study.

Post attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 12

Withdrawal from psychiatric drugs can leave you feeling stuck in a way that is hard to put into words. Days blur together until it feels like groundhog day — the same looping symptoms, the same exhaustion, the same waiting. Hope can feel out of reach for long stretches, even when you are doing everything you can to get through it. If you have lived through this and come out the other side, what message of encouragement would you share with someone who is in the middle of it right now?

Post attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 9

If you are considering an SSRI, or already taking one, it is worth asking about orgasm and satisfaction directly rather than relying on a broad check-in. Specific questions surface what overall scores sometimes miss. 2/3

Post attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 9

🧵 In case you missed it: Finally, researchers are calling for more work on the sexual effects of antidepressants after the drugs are stopped. Published earlier this year, a review of trials comparing SSRIs with placebo found that roughly one in three people on an SSRI had orgasm problems, compared with about one in ten on placebo. That finding matters because orgasm problems have never been part of the formal criteria used to diagnose depression. Reduced interest in sex can sit inside the broader sense of loss of interest or pleasure, but loss of or difficulty reaching orgasm itself has never been listed as a diagnostic feature. Overall questionnaire scores often failed to pick up the difference that showed up when orgasm and satisfaction were examined on their own. A single total number, or a general question about sex, can therefore leave the specific problem unrecorded — both in trials and in ordinary care. Most of the trials ran only about eight weeks. The authors note that longer follow-up is still needed, including on what happens after the drugs are stopped. 1/3

Post attachmentPost attachmentPost attachmentPost attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 5

More people than ever are looking beyond the existing mental health industry. And that means, for our next conference, you’ll find new faces, new thinking, and new ways of working that don’t start and end inside the usual clinical frames. One of those new faces is Sam Fuesy — here’s a little more about her and what you can look forward to from her talk. You can join her January 26–28, 2027 in Boston — link below to get your tickets now.

Post attachmentPost attachmentPost attachmentPost attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 3

Are you supporting a loved one who’s tapering psychiatric drugs and moving on from the mental health industry? If so, our live session tomorrow (November 4) with Yael Abramson is just for you. It’s part of our new Family Support and Learning Community in our mutual aid platform, Inner Compass Exchange. As a young adult, Yael went through five episodes of psychosis and 15 years of suicidal ideation, with repeated hospitalizations. She faced severe trauma and loss and, like so many, was told she would need psychiatric drugs for the rest of her life. Instead, she found her own way off them and, through a different understanding of these experiences, to a place of peace of mind and freedom. Now, as a mentor, she is passing on all she’s learned so you can walk alongside your loved one with clearer understanding and steadier support. You can join the session via the link in below.

Post attachment
Inner Compass Initiative avatar
Inner Compass Initiative@_innercompass·Nov 3

As our founder, @LauraDelano, often says, there is an information crisis around psychiatric drugs. Too many people lack the full information they need to make meaningful choices about starting, continuing, or stopping them. There’s another gap, too: the knowledge and experience of people who have been through the psychiatric system are routinely left out of the conversation. With Laura’s appointment as senior policy adviser at the U.S. Department of Health and Human Services, we hope to see real change: safer prescribing and deprescribing, and meaningful informed choice for everyone, whether or not they want to come off psychiatric drugs. ICI remains independent and nonpartisan. The people we serve come from all walks of life, across political, cultural, and personal backgrounds. Access to comprehensive, unbiased information matters to all of us. Read the article via the link in comments (free subscription required).

Post attachment